Biocon Biologics Limited

Form 483 issued May 1, 2018 · Bangalore, India

Inspection
Apr 23 – May 1, 2018
Observations
2
Pages
4
FEI number
3003981475

In short: On May 1, 2018, FDA issued a Form 483 with 2 observations to Biocon Biologics Limited in Bangalore, Karnataka (FEI 3003981475) after an inspection that ran Apr 23 – May 1, 2018. The investigators were Laura Fontan and Laurie Nelson. Most observations concern facilities & equipment and production; the most-cited regulation is 21 CFR 211.113 (control of microbiological contamination).

At a glance

Facilities & equipment and production account for 2 of 2 observations.

Facilities & equipment1
Production1

Most cited: 21 CFR 211.113 (2×) · 211.67 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Disinfection efficacy is incomplete…

  2. 02

    Environmental monitoring is…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Biocon Biologics Limited?

FDA listed 2 observations on this Form 483, mostly about facilities & equipment and production. The most-cited regulation is 21 CFR 211.113 (control of microbiological contamination). The opening words of each observation are shown on this page.

Who inspected Biocon Biologics Limited?

Laura Fontan and Laurie Nelson are named on this Form 483, for the inspection of Apr 23 – May 1, 2018. Each investigator has a profile showing what they cite most.

When was Biocon Biologics Limited inspected by FDA?

The inspection ran Apr 23 – May 1, 2018, and the Form 483 is dated May 1, 2018.

How do I get the full Form 483 for Biocon Biologics Limited?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free